TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 2 | 4 | 3 | 9 | 23 | 44 | 14 |
| P | %wins | 100 | 100 | 75 | 75 | 100 | 75 | 88 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/22 20:01 | 6/13/22 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Wold Olsen Per | NJ | D | P | 93 | 1.69 | 0 | 55 | 59 | 149 | D | |||||||||||||||
2/10/15 16:30 | 2/6/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wold Olsen Per | CA | D | P | 999 | 99.92 | 33 | 10 | 13 | 88 | D | 140 | 23 | 5 | -9 | 3 | -7 | -7 | -2 | 2 | 6 | 1 | 7 | 19 | -10 | |
3/4/13 15:57 | 2/28/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wold Olsen Per | CA | D | P | 430 | 43.05 | 33 | 10 | 17 | 69 | D | 123 | 89 | 52 | 16 | 12 | 6 | 4 | 3 | 1 | 5 | 11 | 25 | 40 | 87 | |
2/23/12 15:36 | 2/22/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wold Olsen Per | CA | D | P | 440 | 44.00 | 33 | 10 | 62 | 26 | D | -6 | 16 | 18 | 12 | 1 | -9 | -17 | -19 | 1 | 2 | 5 | 13 | 28 | 89 | |
5/5/10 14:15 | 5/4/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wold Olsen Per | CA | D | P | 494 | 38.60 | 33 | 13 | New | 13 | D | -28 | -14 | -9 | -21 | -19 | -16 | -8 | -5 | 4 | 2 | -7 | -11 | 4 | 8 | |
11/19/07 10:37 | 11/16/07 | PDGI | Pharmanet Development Group Inc | DE | Health | Biolab | Commercial Physical & Biologi | Wold Olsen Per | NJ | D | P | 185 | 36.99 | 0 | 5 | 68 | 12 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |